APOL1 proteomic risk score predicts kidney disease progression
A nine-protein apolipoprotein L1 (APOL1) Proteomic Risk Score (APRS) enables accurate prediction of kidney disease progression in APOL1 high-risk individuals, according to a study published online April 15 in Nature Medicine.
ORIGINAL SOURCE →via Medical Xpress
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · health
- [HEALTH] From crisis to commitment: nursing students' sense of belonging during and immediately after the covid-19 pandemic.
- [HEALTH] In the name of immunity, for the sake of the sacred: An analysis of the Iranian government's response to the COVID-19 ou
- [HEALTH] Knowledge, Attitudes, and Practices Regarding Arboviruses at a Human-Wildlife Interface: A Cross-Sectional Study in and
- [HEALTH] How to shore up trust during the "cold-period" between pandemics - closing the public trust gap in pandemic preparedness
- [HEALTH] Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era.
- [HEALTH] Emergency department evaluation and management of serious and high-risk infections in the febrile returning traveler.